Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.

Pfeilschifter W, Bohmann F, Baumgarten P, Mittelbronn M, Pfeilschifter J, Lindhoff-Last E, Steinmetz H, Foerch C.

Ann Neurol. 2012 May;71(5):624-33. doi: 10.1002/ana.23558. Epub 2012 Mar 23.

PMID:
22447744
[PubMed - indexed for MEDLINE]
2.

Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.

Sun L, Zhou W, Ploen R, Zorn M, Veltkamp R.

Thromb Haemost. 2013 Jul;110(1):153-61. doi: 10.1160/TH12-12-0942. Epub 2013 Apr 25.

PMID:
23615682
[PubMed - indexed for MEDLINE]
3.

No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke.

Bohmann F, Mirceska A, Pfeilschifter J, Lindhoff-Last E, Steinmetz H, Foerch C, Pfeilschifter W.

PLoS One. 2012;7(7):e40804. doi: 10.1371/journal.pone.0040804. Epub 2012 Jul 24.

PMID:
22911709
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC.

Pfeilschifter W, Spitzer D, Pfeilschifter J, Steinmetz H, Foerch C.

PLoS One. 2011;6(10):e26087. doi: 10.1371/journal.pone.0026087. Epub 2011 Oct 19.

PMID:
22039437
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.

Takeuchi S, Wada K, Nagatani K, Otani N, Osada H, Nawashiro H.

Acta Neurochir (Wien). 2012 Jan;154(1):87. doi: 10.1007/s00701-011-1196-x. Epub 2011 Oct 25. No abstract available.

PMID:
22037979
[PubMed - indexed for MEDLINE]
6.

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S.

Circulation. 2011 May 31;123(21):2363-72. doi: 10.1161/CIRCULATIONAHA.110.004747. Epub 2011 May 16.

PMID:
21576658
[PubMed - indexed for MEDLINE]
Free Article
7.

Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.

Schaefer JH, Leung W, Wu L, Van Cott EM, Lok J, Whalen M, van Leyen K, Lauer A, van Ryn J, Lo EH, Foerch C.

J Cereb Blood Flow Metab. 2014 May;34(5):870-5. doi: 10.1038/jcbfm.2014.31. Epub 2014 Feb 19.

PMID:
24549187
[PubMed - indexed for MEDLINE]
8.

Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trial.

Hori M, Connolly SJ, Ezekowitz MD, Reilly PA, Yusuf S, Wallentin L; RE-LY Investigators.

Circ J. 2011;75(4):800-5. Epub 2011 Mar 19.

PMID:
21436594
[PubMed - indexed for MEDLINE]
Free Article
9.

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.

Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M; RE-LY Investigators.

Circulation. 2012 Jul 17;126(3):343-8. doi: 10.1161/CIRCULATIONAHA.111.090464. Epub 2012 Jun 14. Erratum in: Circulation. 2012 Sep 4;126(10):e160. Heidbuchle, Hein [corrected to Heidbuchel, Hein].

PMID:
22700854
[PubMed - indexed for MEDLINE]
Free Article
10.

Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.

Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S.

Stroke. 2012 Jun;43(6):1511-7. doi: 10.1161/STROKEAHA.112.650614. Epub 2012 Apr 5.

PMID:
22492518
[PubMed - indexed for MEDLINE]
Free Article
11.

Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.

Ploen R, Sun L, Zhou W, Heitmeier S, Zorn M, Jenetzky E, Veltkamp R.

J Cereb Blood Flow Metab. 2014 Mar;34(3):495-501. doi: 10.1038/jcbfm.2013.226. Epub 2013 Dec 18.

PMID:
24346690
[PubMed - indexed for MEDLINE]
12.

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.

Kamel H, Johnston SC, Easton JD, Kim AS.

Stroke. 2012 Mar;43(3):881-3. doi: 10.1161/STROKEAHA.111.641027. Epub 2012 Feb 3.

PMID:
22308255
[PubMed - indexed for MEDLINE]
Free Article
13.

Dabigatran and thrombolysis: A therapeutic dilemma.

Govindarajan R, Salgado E.

Ann Neurol. 2012 Oct;72(4):625; author reply 625-6. doi: 10.1002/ana.23686. No abstract available.

PMID:
23109156
[PubMed - indexed for MEDLINE]
14.

Rapid reversal of anticoagulation prevents excessive secondary hemorrhage after thrombolysis in a thromboembolic model in rats.

Sun L, Zhou W, Ploen R, Heiland S, Zorn M, Veltkamp R.

Stroke. 2011 Dec;42(12):3524-9. doi: 10.1161/STROKEAHA.110.608059. Epub 2011 Sep 29.

PMID:
21960573
[PubMed - indexed for MEDLINE]
Free Article
15.

Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.

Vergouwen MD, Casaubon LK, Swartz RH, Fang J, Stamplecoski M, Kapral MK, Silver FL; Investigators of the Registry of the Canadian Stroke Network.

Stroke. 2011 Apr;42(4):1041-5. doi: 10.1161/STROKEAHA.110.599183. Epub 2011 Feb 24.

PMID:
21350204
[PubMed - indexed for MEDLINE]
Free Article
16.

Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.

Lauer A, Cianchetti FA, Van Cott EM, Schlunk F, Schulz E, Pfeilschifter W, Steinmetz H, Schaffer CB, Lo EH, Foerch C.

Circulation. 2011 Oct 11;124(15):1654-62. doi: 10.1161/CIRCULATIONAHA.111.035972. Epub 2011 Sep 12.

PMID:
21911784
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.

Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.

Int Angiol. 2012 Aug;31(4):330-9. Review.

PMID:
22801398
[PubMed - indexed for MEDLINE]
18.

Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.

Casado Naranjo I, Portilla-Cuenca JC, Jiménez Caballero PE, Calle Escobar ML, Romero Sevilla RM.

Cerebrovasc Dis. 2011;32(6):614-5. doi: 10.1159/000334578. Epub 2011 Dec 1. No abstract available.

PMID:
22133608
[PubMed - indexed for MEDLINE]
Free Article
19.

Home-monitoring of oral anticoagulation vs. dabigatran. An indirect comparison.

Alonso-Coello P, Zhou Q, Guyatt G.

Thromb Haemost. 2012 Oct;108(4):647-53. Epub 2012 Aug 23. Review.

PMID:
22918481
[PubMed - indexed for MEDLINE]
20.

Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.

Xian Y, Liang L, Smith EE, Schwamm LH, Reeves MJ, Olson DM, Hernandez AF, Fonarow GC, Peterson ED.

JAMA. 2012 Jun 27;307(24):2600-8. doi: 10.1001/jama.2012.6756.

PMID:
22735429
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk